Keele Research Repository

Article

Oswald, AJ, Symeonides, SN, Wheatley, D, Chan, S, Brunt, AM ORCID: https://orcid.org/0000-0002-4797-5097, McAdam, K, Schmid, P, Waters, S, Poole, C, Twelves, C, Perren, T, Bartlett, J, Piper, T, Chisholm, EM, Welsh, M, Hill, R, Hopcroft, LEM, Barrett-Lee, P and Cameron, DA (2023) Aromatase inhibition plus/minus Src inhibitor saracatinib (AZD0530) in advanced breast cancer therapy (ARISTACAT): a randomised phase II study. Breast Cancer Research and Treatment.

Bundred, N, Porta, N, Brunt, AM ORCID: https://orcid.org/0000-0002-4797-5097, Cramer, A, Hanby, A, Shaaban, AM, Rakha, EA, Armstrong, A, Cutress, RI, Dodwell, D, Emson, MA, Evans, A, Hartup, SM, Horgan, K, Miller, SE, McIntosh, SA, Morden, JP, Naik, J, Narayanan, S, Ooi, J, Skene, AI, Cameron, DA and Bliss, JM (2022) Combined Perioperative Lapatinib and Trastuzumab in Early HER2-Positive Breast Cancer Identifies Early Responders: Randomized UK EPHOS-B Trial Long-Term Results. Clinical Cancer Research, 28 (7). 1323 - 1334.